Skip to content

Exercise Response After Revalidation in Cancer Patients

Role of Myocardial Work in the Prediction of Cardiac Dysfunction and Response After Revalidation in Patients With Cancer Undergoing Chemotherapy and/or Radiotherapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04461392
Enrollment
191
Registered
2020-07-08
Start date
2020-08-31
Completion date
2022-08-31
Last updated
2020-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Toxicity, Oncology

Keywords

Echocardiography, Revalidation, Cardiovascular magnetic resonance imaging, Oncology, Radiotherapy, Chemotherapy, Cardiorespiratory exercise test

Brief summary

This study regarding oncological patients for rehabilitation after specific cancer therapy involves three aims: (1) to evaluate the predictive value of myocardial work parameters on the improvement of exercise performance after rehabilitation, (2) to determine which echocardiographic parameters are more suitable in predicting cardiac dysfunction, and (3) to evaluate the correlation between echocardiographic parameters and fibrosis detected by cardiac magnetic resonance imaging (CMR).

Detailed description

Myocardial work (MW) provides an estimation of cardiac function by combining global longitudinal strain (GLS) with blood pressure values obtained non-invasively, being less load dependent than standard GLS. The investigator hypothesize that myocardial work could be a useful marker for predicting the exercise performance after chemotherapy and/or radiotherapy in oncological patients undergoing rehabilitation. Moreover, this study may provide additional information in optimal selection for rehabilitation programs.

Interventions

DIAGNOSTIC_TESTCardiorespiratory exercise test

* Cardiorespiratory exercise test to evaluate the exercise tolerance * Cardiac imaging for the assessment of the left atrium anatomy and function.

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patients diagnosed with cancer 2. Undergoing chemotherapy and/or radiotherapy/hormone therapy 3. Age older than 18 years old - maximum age of 90 years old 4. Willing to enter revalidation in Universitair Ziekenhuis Brussel 5. Signed consent form

Exclusion criteria

1. Severe aortic stenosis defined as aortic valve aria under 0.6 cm2/m2 2. Supraventricular arrhythmias 3. Poor image quality for 2D and 3D echocardiography defined as the impossibility to examine of more than 2 adjacent segments 4. Resistant hypertension defined as uncontrolled blood pressure values under current European guidelines, Systolic Blood Pressure more than 140 mmHg and/or Diastolic Blood Pressure more than 80 mmHg 5. Lung cancer

Design outcomes

Primary

MeasureTime frameDescription
Change in peak volume oxygen - VO2 (L/min)change from baseline (before rehabilitation) at 15 months (after rehabilitation)represents the maximum oxygen consumption during incremental exercise that is measured during Cardiopulmonary Exercise test (CPET), being a measure of aerobic capacity of the subject
Change in the minute ventilation/carbon dioxide production (VE/VCO2) slopechange from baseline (before rehabilitation) at 15 months (after rehabilitation)this parameter shows the increase in ventilation in response to CO2 production, thus it measures the ventilatory efficiency
Change in the respiratory exchange ratio (RER)change from baseline (before rehabilitation) at 15 months (after rehabilitation)represents the ratio between exhaled CO2 and inhale O2 may quantify the grade of the effort

Secondary

MeasureTime frameDescription
Change in myocardial work (MW)change from baseline (before rehabilitation) at 15 months (after rehabilitation)Myocardial work (MW) is a non-invasive, less load-dependent echocardiographic parameter obtained during standard transthoracic echography using the pressure-strain loop data. This parameter consists of the following measurements: Global constructive work (GCW) Global wasted work (GWW), Global work index (GWI), and Global work efficiency (GWE)
Change in health statuschange from baseline (before rehabilitation) at 15 months (after rehabilitation)Self-assessment of the generic health status using the EQ-5D-5L questionnaire. This questionnaire assesses health status in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, on a five-level scale. In the evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS) from 0 ('the worst health you can imagine') - 100 ('the best health you can imagine')
Major adverse cardiovascular events (MACE)through study completion, an average of 1 yearnonfatal stroke, nonfatal myocardial infarction, and cardiovascular death

Countries

Belgium

Contacts

Primary ContactSteven Droogmans, Professor
steven.droogmans@uzbrussel.be024776009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026